Seoul Viosys promotes violeds to sterilize coronavirus

Korea |  News | 0 Comment | 24 Aug, 2020

South Korea based Seoul Viosys, is promoting new Violeds technology solution, the world’s first ultraviolet LED te...Read more

KT Corp develops AI-based COVID-19 research

Korea |  News | 0 Comment | 21 Aug, 2020

KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment...Read more

South Korean church donates plasma worth $83B for COVID-19 cure

Korea |  News | 1 Comment | 20 Aug, 2020

At a time when the entire world is reeling under the impact of COVID-19, members of Shincheonji Church from South Korea ...Read more

LG Chem & TransThera Bio to work on chronic inflammatory conditions

Korea |  News | 0 Comment | 18 Aug, 2020

South Korean firm LG Chem Life Sciences, a division of LG Chem, and TransThera Biosciences Co. Ltd., a clinical-stage bi...Read more

Novavax, SK Bioscience announce COVID-19 vaccine collaboration

Korea |  News | 0 Comment | 17 Aug, 2020

US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...Read more

Samsung Biologics invests $2B for further expansion

Korea |  News | 0 Comment | 13 Aug, 2020

  South Korea based Samsung Biologics held an online press conference to announce its plans to break ground for a ...Read more

Celltrion to launch antigen and antibody testing kits in US

Korea |  News | 0 Comment | 14 Aug, 2020

South Korea based Celltrion Group recently announced the launch of two rapid kits for SARS-CoV-2 in the US by the third ...Read more

Mankind, Daewoong Pharma to use Niclosamide for COVID-19 treatment

Korea |  News | 0 Comment | 11 Aug, 2020

Daewoong Pharmaceutical Co. Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mank...Read more

Merck & Hanmi to develop, commercialise therapy for NASH

Korea |  News | 0 Comment | 12 Aug, 2020

Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...Read more

Samsung Biologics launches S-CHOice cell line expression technology

Korea |  News | 0 Comment | 06 Aug, 2020

South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...Read more

Macrogen obtains CE-IVD mark for COVID-19 test kit

Korea |  News | 0 Comment | 04 Aug, 2020

Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...Read more

PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

Korea |  News | 0 Comment | 05 Aug, 2020

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...Read more

GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19

Korea |  News | 0 Comment | 03 Aug, 2020

Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...Read more

Seegene receives expanded EUA for COVID-19 diagnostic assay

Korea |  News | 0 Comment | 31 Jul, 2020

South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...Read more

Samsung Biologics expands drug product manufacturing facility in Incheon

Korea |  News | 0 Comment | 24 Jul, 2020

South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...Read more

Celltrion launches human trial of potential COVID-19 Ab treatment

Korea |  News | 0 Comment | 23 Jul, 2020

South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...Read more

Samsung Biologics announces strong results for Q2 FY21

Korea |  News | 0 Comment | 22 Jul, 2020

South Korea based Samsung Biologics recently announced strong financial results for its fiscal 2020 second quarter endin...Read more

CGBIO to seize Korean premium filler market

Korea |  News | 0 Comment | 22 Jul, 2020

CGBIO, first medical healthcare company to successfully develop an aesthetic premium filler 'Giselleligne' using the R2 ...Read more